DCAF13 and breast carcinoma: As shown in Fig. 2D–F, the epithelial cell marker β‐catenin was upregulated, whereas the mesenchymal cell marker fibronectin was downregulated upon DCAF13 knockdown, suggesting that DCAF13 promotes EMT in human breast cancer.